Search

everythinglearnresearchcommunity

for

Search:↓

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Polycomb Repressive Complex 2 is not needed for hair regeneration.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Eating less can improve stem cell function and increase lifespan.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.